These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

348 related items for PubMed ID: 15199752

  • 1. [Hairy cell leukemia, Japanese variant, successfully treated with cladribine].
    Miyazaki M, Taguchi A, Sakuragi S, Mitani N, Matsuda K, Shinohara K.
    Rinsho Ketsueki; 2004 May; 45(5):405-7. PubMed ID: 15199752
    [Abstract] [Full Text] [Related]

  • 2. [Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia].
    Terasaki Y, Okumura H, Hirose A, Ishiura Y, Yokawa S, Saito K, Nakao S.
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1885-8. PubMed ID: 18030031
    [Abstract] [Full Text] [Related]

  • 3. [Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia].
    Araki H, Matsunaga T, Murase K, Kuroda H, Kuribayashi K, Terui T, Niitsu Y.
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):965-9. PubMed ID: 15222122
    [Abstract] [Full Text] [Related]

  • 4. [European-American-type hairy cell leukemia without splenomegaly, treated successfully with deoxycoformycin].
    Muta T, Okamura T, Oshima K, Kikuchi M, Niho Y.
    Rinsho Ketsueki; 2001 May; 42(5):426-31. PubMed ID: 11452464
    [Abstract] [Full Text] [Related]

  • 5. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
    Konwalinka G, Schirmer M, Hilbe W, Fend F, Geisen F, Knoblechner A, Petzer A, Thaler J.
    Blood Cells Mol Dis; 1995 May; 21(2):142-51. PubMed ID: 8846043
    [Abstract] [Full Text] [Related]

  • 6. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O, Tomová A, Kusenda J, Gyárfás J.
    Neoplasma; 2001 May; 48(5):350-7. PubMed ID: 11845978
    [Abstract] [Full Text] [Related]

  • 7. Hairy cell leukemia (HCL) with extensive myelofibrosis responds to thalidomide.
    Strupp C, Fenk R, Kündgen A, Gattermann N, Haas R, Germing U.
    Leuk Res; 2005 Aug; 29(8):967-9. PubMed ID: 15978949
    [Abstract] [Full Text] [Related]

  • 8. [Successful treatment of hairy cell leukemia with pentostatin].
    Fujita H, Koharazawa H, Nishida H, Terada S, Morishita T, Kuroyama Y, Ohata M, Ishigatsubo Y.
    Rinsho Ketsueki; 2001 Jul; 42(7):537-42. PubMed ID: 11524843
    [Abstract] [Full Text] [Related]

  • 9. [Monitoring minimal residual disease in patients with hairy cell leukemia in complete remission after treatment with 2-chlorodioxyadenosine].
    Zák P, Chrobák L, Dĕdic K, Podzimek K.
    Vnitr Lek; 2000 Oct; 46(10):697-703. PubMed ID: 11344629
    [Abstract] [Full Text] [Related]

  • 10. [Hairy cell leukemia successfully treated with deoxycoformycin].
    Matsuda A, Jinnai I, Mizuno H, Sakata T, Kusumoto S, Kayano H, Takeuchi H, Bessho M, Saito M, Katayama I.
    Rinsho Ketsueki; 1992 Nov; 33(11):1685-90. PubMed ID: 1469784
    [Abstract] [Full Text] [Related]

  • 11. [Successful treatment with cladribine for hypoplastic hairy cell leukemia after long-term neutropenia].
    Sakai R, Yamazaki E, Sakamoto H, Kanamori H, Ishigatsubo Y.
    Rinsho Ketsueki; 2005 Nov; 46(11):1187-90. PubMed ID: 16440801
    [Abstract] [Full Text] [Related]

  • 12. [Polyclonal B-cell lymphocytosis with clinical and hematological features resembling hairy cell leukemia].
    Kanbayashi H, Nagata K, Tanaka T, Matsuda S, Sakuma H, Maruyama Y, Machii T.
    Rinsho Ketsueki; 1998 Jul; 39(7):493-8. PubMed ID: 9750456
    [Abstract] [Full Text] [Related]

  • 13. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia.
    Yang MH, Ho CH.
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):54-8. PubMed ID: 11310372
    [Abstract] [Full Text] [Related]

  • 14. Effect of 2-chlorodeoxyadenosine therapy on bone marrow fibrosis in hairy cell leukemia.
    Dedic K, Zák P.
    Neoplasma; 2004 Jan; 51(1):56-8. PubMed ID: 15004661
    [Abstract] [Full Text] [Related]

  • 15. Development of hairy cell leukemia in a patient with antiphospholipid syndrome.
    Diz-Kucukkaya R, Dincol G, Kamali S, Kural F, Inanc M.
    Lupus; 2007 Jan; 16(4):286-8. PubMed ID: 17439936
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of hairy cell leukemia with cladribine].
    Aurer I, Mitrović Z, Kovacević-Metelko J, Radman I, Basić-Kinda S, Gjadrov-Kuvezdić K, Jakić-Razumović J, Dubravcić K, Ries S, Nola M, Zupancic-Salek S, Labar B.
    Lijec Vjesn; 2007 Jan; 129(3-4):80-3. PubMed ID: 17557550
    [Abstract] [Full Text] [Related]

  • 17. [50-year-old man with weight loss and splenomegaly].
    Austein T, Schmitt A.
    Dtsch Med Wochenschr; 2009 Feb; 134(6):251-2. PubMed ID: 19180417
    [No Abstract] [Full Text] [Related]

  • 18. The role of interleukin-6 in a patient with polyclonal hairy B-cell lymphoproliferative disorder: a case report.
    Okamoto A, Inaba T, Fujita N.
    Lab Hematol; 2007 Feb; 13(4):124-7. PubMed ID: 18192143
    [Abstract] [Full Text] [Related]

  • 19. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment].
    Urasiński I, Zdziarska B, Krygier-Stojałowska A.
    Acta Haematol Pol; 1996 Feb; 27(1):49-55. PubMed ID: 8629443
    [Abstract] [Full Text] [Related]

  • 20. Cladribine: from the bench to the bedside--focus on hairy cell leukemia.
    Greyz N, Saven A.
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):745-57. PubMed ID: 15485311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.